Literature DB >> 2491762

The cost-effectiveness of counseling smokers to quit.

S R Cummings1, S M Rubin, G Oster.   

Abstract

Cigarette smoking is the most important preventable cause of death in the United States. Surveys of patients, however, suggest that many physicians do not routinely counsel smokers to quit. Because physicians may not consider counseling against smoking to be as worthwhile as other medical practices, we examined its cost-effectiveness. We based our estimates of the effectiveness of physician counseling on published reports of randomized trials and our estimates of its cost on average charges for physician office visits. Our results indicate that the cost-effectiveness of brief advice during routine office visits ranges from $705 to $988 per year of life saved for men and from $1204 to $2058 for women. Follow-up visits about smoking appear to be similarly cost-effective. Physician counseling against smoking, therefore, is at least as cost-effective as several other preventive medical practices and should be a routine part of health care for patients who smoke.

Entities:  

Mesh:

Year:  1989        PMID: 2491762

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  48 in total

1.  Guidance for commissioners on the cost effectiveness of smoking cessation interventions. Health Educational Authority.

Authors:  S Parrott; C Godfrey; M Raw; R West; A McNeill
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

2.  Labeling smokers' charts with a "smoker" sticker: results of a randomized controlled trial among private practitioners.

Authors:  J F Etter; J C Rielle; T V Perneger
Journal:  J Gen Intern Med       Date:  2000-06       Impact factor: 5.128

3.  Coverage of smoking cessation treatment by union health and welfare funds.

Authors:  E M Barbeau; Y I Li; G Sorensen; K M Conlan; R Youngstrom; K Emmons
Journal:  Am J Public Health       Date:  2001-09       Impact factor: 9.308

Review 4.  The limited incorporation of economic analyses in clinical practice guidelines.

Authors:  Joel F Wallace; Scott R Weingarten; Chiun-Fang Chiou; James M Henning; Andriana A Hohlbauch; Margaret S Richards; Nicole S Herzog; Lior S Lewensztain; Joshua J Ofman
Journal:  J Gen Intern Med       Date:  2002-03       Impact factor: 5.128

Review 5.  Preventive mental health and substance abuse programs and services in managed care.

Authors:  Sharon L Dorfman; Shelagh A Smith
Journal:  J Behav Health Serv Res       Date:  2002-08       Impact factor: 1.505

6.  Long-term impact of smoking cessation on the incidence of coronary heart disease.

Authors:  A N Tosteson; M C Weinstein; L W Williams; L Goldman
Journal:  Am J Public Health       Date:  1990-12       Impact factor: 9.308

Review 7.  Cost effectiveness of smoking-cessation therapies. Interpretation of the evidence-and implications for coverage.

Authors:  K E Warner
Journal:  Pharmacoeconomics       Date:  1997-06       Impact factor: 4.981

8.  Cost-effectiveness of extended cessation treatment for older smokers.

Authors:  Paul G Barnett; Wynnie Wong; Abra Jeffers; Ricardo Munoz; Gary Humfleet; Sharon Hall
Journal:  Addiction       Date:  2013-12-13       Impact factor: 6.526

Review 9.  Over-the-counter nicotine replacement therapy: can its impact on smoking cessation be enhanced?

Authors:  Nancy Amodei; R J Lamb
Journal:  Psychol Addict Behav       Date:  2008-12

Review 10.  Management of the hypertensive patient who smokes.

Authors:  H Pardell; R Tresserras; E Saltó; P Armario; R Hernández
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.